Related Experiment Video
Updated: May 3, 2026

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
19.6K
Robotic Vena Cava Thrombectomy with Three-dimensional Augmented Reality Guidance.
Daniele Amparore1, Enrico Checcucci2, Federico Piramide1
1Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.
European Urology Open Science
|March 4, 2024
Summary
Three-dimensional augmented reality (3D AR) enhances robotic surgery for renal cell carcinoma (RCC) with venous thrombus. This technology aids in precise thrombus localization, improving surgical strategy and patient outcomes.
Area of Science:
- Urology
- Surgical Oncology
- Medical Technology
Background:
- Robotic surgery is increasingly utilized for renal cell carcinoma (RCC) involving neoplastic thrombus in the renal vein or inferior vena cava (IVC).
- Precise identification of thrombus extent is critical for successful surgical intervention.
- Three-dimensional augmented reality (3D AR) offers potential for enhanced visualization during complex procedures.
Observation:
- A prospective study enrolled five patients with nonmetastatic RCC and level 0-I venous thrombus undergoing robot-assisted radical nephrectomy and thrombectomy with 3D AR guidance.
- The 3D AR system was employed to visualize and delineate the thrombus location within the renal vein and IVC.
- Surgical metrics included operative time (mean 123 min), IVC clamping time (mean 9.4 min), and estimated blood loss (mean 750 ml).
Findings:
- The 3D AR system accurately identified thrombus location in all five patients.
- Surgeons utilized the 3D AR guidance to correctly estimate thrombus margins and inform surgical strategy.
- No intraoperative complications or significant postoperative complications (Clavien-Dindo grade >2) were reported.
Implications:
- 3D AR guidance can improve the precision of robotic surgery for RCC with venous thrombus.
- Enhanced visualization may lead to optimized surgical planning and execution, potentially reducing complications.
- This technology holds promise for improving outcomes in complex oncologic surgeries involving vascular structures.

